Phosphodiesterase inhibitor for heart failure with preserved ejection fraction: A systematic review and meta-analysis.

Chen, Zhu; Zhao, Kaixuan; Xiao, Changhu; He, Ziyu; Liu, Sha; Wu, Xuemei; Shi, Shuting; Guo, Yuan

Chen, Zhu; Zhao, Kaixuan; Xiao, Changhu; He, Ziyu; Liu, Sha; Wu, Xuemei; Shi, Shuting; Guo, Yuan.

Afiliación

Chen Z; Department of Cardiovascular Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, Hunan, China.
Zhao K; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.
Xiao C; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.
He Z; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.
Liu S; Department of Research Laboratory, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, Hunan, China.
Wu X; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.
Shi S; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.
Guo Y; Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, Hunan, China.

Saudi Pharm J ; 30(8): 1079-1087, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36164567

Palabras clave

6MWT, 6-minute walking test; 95% CIs, 95% confidence intervals; BD, baseline data; CD, change data; E/e', early diastolic mitral inflow to annular velocities; FD, final data; HFpEF, heart failure with preserved ejection fraction; Heart failure with preserved ejection fraction; KCCQ, Kansas City cardiomyopathy questionnaire; LAVI, left atrial volume index; LV, left ventricular; MeSH, Medical Subject Heading; Meta-analysis; NT-proBNP, N-terminal fragment of the precursor to brain-type natriuretic peptide; PAP, pulmonary arterial pressure; PASP, pulmonary artery systolic pressure; PDE, phosphodiesterase; PH, pulmonary hypertension; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; PVR, pulmonary vascular resistance; Phosphodiesterase inhibitor; QOL, quality of life; RCTs, randomized controlled trials; RR, risk ratio; RV, right ventricular; Right ventricular dysfunction; SMD, standardized mean difference; TAPSE, tricuspid annular plane systolic excursion; VO2, oxygen uptake; cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Saudi Pharm J Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google